659 related articles for article (PubMed ID: 25869810)
1. Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.
Matos M; Shen HY; Augusto E; Wang Y; Wei CJ; Wang YT; Agostinho P; Boison D; Cunha RA; Chen JF
Biol Psychiatry; 2015 Dec; 78(11):763-74. PubMed ID: 25869810
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-α2 controlling glutamate uptake in astrocytes.
Matos M; Augusto E; Agostinho P; Cunha RA; Chen JF
J Neurosci; 2013 Nov; 33(47):18492-502. PubMed ID: 24259572
[TBL] [Abstract][Full Text] [Related]
3. Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake.
Matos M; Augusto E; Machado NJ; dos Santos-Rodrigues A; Cunha RA; Agostinho P
J Alzheimers Dis; 2012; 31(3):555-67. PubMed ID: 22647260
[TBL] [Abstract][Full Text] [Related]
4. Knocking out the glial glutamate transporter GLT-1 reduces glutamate uptake but does not affect hippocampal glutamate dynamics in early simulated ischaemia.
Hamann M; Rossi DJ; Marie H; Attwell D
Eur J Neurosci; 2002 Jan; 15(2):308-14. PubMed ID: 11849297
[TBL] [Abstract][Full Text] [Related]
5. Roles of the NMDA Receptor and EAAC1 Transporter in the Modulation of Extracellular Glutamate by Low and High Affinity AMPA Receptors in the Cerebellum in Vivo: Differential Alteration in Chronic Hyperammonemia.
Cabrera-Pastor A; Taoro L; Llansola M; Felipo V
ACS Chem Neurosci; 2015 Dec; 6(12):1913-21. PubMed ID: 26428532
[TBL] [Abstract][Full Text] [Related]
6. Genetic blockade of adenosine A2A receptors induces cognitive impairments and anatomical changes related to psychotic symptoms in mice.
Moscoso-Castro M; Gracia-Rubio I; Ciruela F; Valverde O
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1227-40. PubMed ID: 27133030
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors.
Pintor A; Galluzzo M; Grieco R; Pèzzola A; Reggio R; Popoli P
J Neurochem; 2004 Apr; 89(1):152-6. PubMed ID: 15030399
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element.
Ghosh M; Lane M; Krizman E; Sattler R; Rothstein JD; Robinson MB
J Neurochem; 2016 Jan; 136(2):262-75. PubMed ID: 26485579
[TBL] [Abstract][Full Text] [Related]
9. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
[TBL] [Abstract][Full Text] [Related]
10. Selective blockade of astrocytic glutamate transporter GLT-1 with dihydrokainate prevents neuronal death during ouabain treatment of astrocyte/neuron cocultures.
Kawahara K; Hosoya R; Sato H; Tanaka M; Nakajima T; Iwabuchi S
Glia; 2002 Dec; 40(3):337-49. PubMed ID: 12420313
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity.
Moidunny S; Matos M; Wesseling E; Banerjee S; Volsky DJ; Cunha RA; Agostinho P; Boddeke HW; Roy S
J Neuroinflammation; 2016 Jun; 13(1):144. PubMed ID: 27287400
[TBL] [Abstract][Full Text] [Related]
12. A novel role of spinal astrocytic connexin 43: mediating morphine antinociceptive tolerance by activation of NMDA receptors and inhibition of glutamate transporter-1 in rats.
Shen N; Mo LQ; Hu F; Chen PX; Guo RX; Feng JQ
CNS Neurosci Ther; 2014 Aug; 20(8):728-36. PubMed ID: 24629168
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of substrate transport-induced clustering of a glial glutamate transporter GLT-1 in astroglial-neuronal cultures.
Nakagawa T; Otsubo Y; Yatani Y; Shirakawa H; Kaneko S
Eur J Neurosci; 2008 Nov; 28(9):1719-30. PubMed ID: 18973588
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A₂A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation.
Shen HY; Canas PM; Garcia-Sanz P; Lan JQ; Boison D; Moratalla R; Cunha RA; Chen JF
PLoS One; 2013; 8(11):e80902. PubMed ID: 24312250
[TBL] [Abstract][Full Text] [Related]
15. Role of neuronal NR2B subunit-containing NMDA receptor-mediated Ca2+ influx and astrocytic activation in cultured mouse cortical neurons and astrocytes.
Kato H; Narita M; Miyatake M; Yajima Y; Suzuki T
Synapse; 2006 Jan; 59(1):10-7. PubMed ID: 16235228
[TBL] [Abstract][Full Text] [Related]
16. Deletion of Neuronal GLT-1 in Mice Reveals Its Role in Synaptic Glutamate Homeostasis and Mitochondrial Function.
McNair LF; Andersen JV; Aldana BI; Hohnholt MC; Nissen JD; Sun Y; Fischer KD; Sonnewald U; Nyberg N; Webster SC; Kapur K; Rimmele TS; Barone I; Hawks-Mayer H; Lipton JO; Hodgson NW; Hensch TK; Aoki CJ; Rosenberg PA; Waagepetersen HS
J Neurosci; 2019 Jun; 39(25):4847-4863. PubMed ID: 30926746
[TBL] [Abstract][Full Text] [Related]
17. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking.
Hughes EG; Maguire JL; McMinn MT; Scholz RE; Sutherland ML
Brain Res Mol Brain Res; 2004 May; 124(2):114-23. PubMed ID: 15135219
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of calcium binding protein, S100A6, in activated astrocytes is linked to glutamate toxicity.
Yamada J; Jinno S
Neuroscience; 2012 Dec; 226():119-29. PubMed ID: 22982625
[TBL] [Abstract][Full Text] [Related]
19. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis.
Vermeiren C; Hemptinne I; Vanhoutte N; Tilleux S; Maloteaux JM; Hermans E
J Neurochem; 2006 Feb; 96(3):719-31. PubMed ID: 16371010
[TBL] [Abstract][Full Text] [Related]
20. Glia mechanisms in mood regulation: a novel model of mood disorders.
Lee Y; Gaskins D; Anand A; Shekhar A
Psychopharmacology (Berl); 2007 Mar; 191(1):55-65. PubMed ID: 17225169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
